HRP20100357T1 - Beta-kristalni oblik soli perindoprilarginina, postupak njegove priprave i farmaceutske smjese koje ga sadrže - Google Patents

Beta-kristalni oblik soli perindoprilarginina, postupak njegove priprave i farmaceutske smjese koje ga sadrže Download PDF

Info

Publication number
HRP20100357T1
HRP20100357T1 HR20100357T HRP20100357T HRP20100357T1 HR P20100357 T1 HRP20100357 T1 HR P20100357T1 HR 20100357 T HR20100357 T HR 20100357T HR P20100357 T HRP20100357 T HR P20100357T HR P20100357 T1 HRP20100357 T1 HR P20100357T1
Authority
HR
Croatia
Prior art keywords
crystalline form
expressed
formula
compound
theta
Prior art date
Application number
HR20100357T
Other languages
English (en)
Croatian (hr)
Inventor
Coquerel G�rard
Lefebvre Loïc
Souvie Jean-Claude
Authouart Pascale
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20100357T1 publication Critical patent/HRP20100357T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
HR20100357T 2006-02-28 2007-02-26 Beta-kristalni oblik soli perindoprilarginina, postupak njegove priprave i farmaceutske smjese koje ga sadrže HRP20100357T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601747A FR2897865B1 (fr) 2006-02-28 2006-02-28 Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
PCT/FR2007/000334 WO2007099216A2 (fr) 2006-02-28 2007-02-26 FORME CRISTALLINE β DU SEL D'ARGININE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (1)

Publication Number Publication Date
HRP20100357T1 true HRP20100357T1 (hr) 2010-07-31

Family

ID=37198804

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100357T HRP20100357T1 (hr) 2006-02-28 2007-02-26 Beta-kristalni oblik soli perindoprilarginina, postupak njegove priprave i farmaceutske smjese koje ga sadrže

Country Status (30)

Country Link
US (1) US7923569B2 (sr)
EP (1) EP2016051B1 (sr)
JP (1) JP5611524B2 (sr)
KR (1) KR20080106947A (sr)
CN (1) CN101389604B (sr)
AT (1) ATE465992T1 (sr)
AU (1) AU2007220434B2 (sr)
BR (1) BRPI0708291B8 (sr)
CA (1) CA2643803C (sr)
CY (1) CY1110082T1 (sr)
DE (1) DE602007006176D1 (sr)
DK (1) DK2016051T3 (sr)
EA (1) EA014715B1 (sr)
ES (1) ES2345291T3 (sr)
FR (1) FR2897865B1 (sr)
GE (1) GEP20135839B (sr)
HR (1) HRP20100357T1 (sr)
MA (1) MA30277B1 (sr)
ME (1) ME01805B (sr)
MX (1) MX2008010747A (sr)
MY (1) MY143557A (sr)
NO (1) NO341238B1 (sr)
NZ (1) NZ570366A (sr)
PL (1) PL2016051T3 (sr)
PT (1) PT2016051E (sr)
RS (1) RS51431B (sr)
SI (1) SI2016051T1 (sr)
UA (1) UA89904C2 (sr)
WO (1) WO2007099216A2 (sr)
ZA (1) ZA200807025B (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2897866B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
AU2013245523C1 (en) * 2008-06-24 2017-09-07 Tianish Laboratories Private Limited Novel polymorphic forms of Perindopril (L)-Arginine and process for the preparation thereof
HUE025982T2 (en) 2008-06-24 2016-05-30 Mylan Laboratories Ltd New polymorphic forms of perindopril (L) -arginine and a process for their preparation
AU2009212902A1 (en) 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
FR2985511B1 (fr) * 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril

Also Published As

Publication number Publication date
UA89904C2 (ru) 2010-03-10
CN101389604B (zh) 2013-08-21
EA014715B1 (ru) 2011-02-28
JP2009529500A (ja) 2009-08-20
US7923569B2 (en) 2011-04-12
SI2016051T1 (sl) 2010-07-30
DK2016051T3 (da) 2010-08-09
BRPI0708291B1 (pt) 2021-02-02
HK1129668A1 (en) 2009-12-04
DE602007006176D1 (de) 2010-06-10
KR20080106947A (ko) 2008-12-09
AU2007220434A1 (en) 2007-09-07
GEP20135839B (en) 2013-06-10
MX2008010747A (es) 2008-09-01
CY1110082T1 (el) 2015-01-14
ES2345291T3 (es) 2010-09-20
JP5611524B2 (ja) 2014-10-22
MA30277B1 (fr) 2009-03-02
RS51431B (sr) 2011-04-30
CA2643803A1 (fr) 2007-09-07
BRPI0708291B8 (pt) 2021-05-25
CA2643803C (fr) 2017-08-08
PT2016051E (pt) 2010-05-13
BRPI0708291A2 (pt) 2011-05-24
NO20083506L (no) 2008-08-13
PL2016051T3 (pl) 2010-08-31
ME01805B (me) 2011-04-30
ATE465992T1 (de) 2010-05-15
EP2016051B1 (fr) 2010-04-28
MY143557A (en) 2011-05-31
EP2016051A2 (fr) 2009-01-21
FR2897865A1 (fr) 2007-08-31
NO341238B1 (no) 2017-09-25
WO2007099216A2 (fr) 2007-09-07
ZA200807025B (en) 2009-11-25
CN101389604A (zh) 2009-03-18
WO2007099216A3 (fr) 2007-10-25
FR2897865B1 (fr) 2008-04-18
NZ570366A (en) 2011-05-27
AU2007220434B2 (en) 2010-10-14
EA200801772A1 (ru) 2009-02-27
US20090186934A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
HRP20100357T1 (hr) Beta-kristalni oblik soli perindoprilarginina, postupak njegove priprave i farmaceutske smjese koje ga sadrže
HRP20140666T1 (hr) Kristalni oblici derivata 2-tiazolil-4-kinolinil-oksi, snažnog hcv-inhibitora
HRP20160644T1 (hr) Kristalni oblik argininske soli perindoprila, postupak njegove priprave te farmaceutski pripravci koji ga sadrže
MY148319A (en) New crystalline form vi of agomelatine, a process for its preparation and pharmaceutical compositions containing it
AR034124A1 (es) Forma cristalina alfa de la sal de terbutilamina de perindopril, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
CA2669849A1 (en) Crystalline forms of (3s)-3-[n-(n'-(2-tert-butylphenyl)oxamyl)alaninyl]amino-5-(2',3',5',6'-tetrafluorophenoxy)-4-oxopentanoic acid
TW200736198A (en) New crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200736197A (en) New crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
HRP20131164T1 (hr) Delta kristalni oblik argininske soli perindoprila, postupak za njegovu pripremu i farmaceutske pripravke koji ga sadrže
WO2008100651A3 (en) Preparation of darifenacin and its salts
JP2020503330A5 (sr)
CN101619070B (zh) 一种替诺昔康的制备方法
WO2006117314A3 (en) Novel piperidin- substituted indoles and their use as ccr-3 modulators
RU2014127478A (ru) Кристаллические формы[(s)-1-карбамоил-2-(фенилпиримидин-2-иламино)этил]амида 2-(2-метиламинопиримидин-4-ил)-1н-индол-5-карбоновой кислоты
RU2012141644A (ru) Новые полиморфы и соли
Lal Sphalerite: a natural catalyst for an efficient synthesis of 2-aminobenzothiazolomethyl naphthol derivatives under solvent-free conditions
MA28192A1 (fr) NOUVELLE FORME CRISTALLINE ß DU SEL DE TERT-BUTYLAMINE DU PERINDOPRILL, SON PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT.
EA200971031A1 (ru) Моногидрохлориды ингибитора гистондеацетилазы
TH87172B (th) ผลึกรูปแบบ v ชนิดใหม่ของอะโกเมลาทีน, กรรมวิธีในการเตรียมและองค์ประกอบทางเภสัชกรรมซึ่งมีสารนี้
MA28189A1 (fr) Nouvelle forme cristalline y du sel de tert-butylamine du perindoprill, son procede de preparation et les compositions pharmaceutiques qui la contiennent
TH98873B (th) อนุพันธ์เอริลไพเพอราซีนและการใช้ประโยชน์ของมัน
TH88291B (th) ผลึกรูปแบบ iv ชนิดใหม่ของอะโกเมลาทีน, กรรมวิธีในการเตรียมและองค์ประกอบทางเภสัชกรรมซึ่งมีสารนี้
MY138209A (en) New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
MA28191A1 (fr) Nouvelle forme cristalline "alpha" du sel de tert -butylamine du perindoprill, son procede de preparation et les compositions pharmaceutiques qui la contiennent.
RU2417222C3 (ru) Соли яблочной кислоты и полиморфы (3s,5s)-7-[3-амино-5-метилпиперидинил]-1-циклопропил-1,4-дигидро-8-метокси-4-оксо-3-хинолинкарбоновой кислоты